?

CRSP · Biotech

CRISPR Therapeutics

Pioneer in approved gene-editing therapies.

Price

…

$42.10

-1.20% today

AI Opportunity Score

69 / 100

Estimate, not a recommendation.

Risk for beginners

Higher

Industry

Biotech

Emerging growth theme

Price trend · CRISPR Therapeutics

Loading trend…
Loading price history…

Educational only · Past performance does not guarantee future results.

AI-generated estimates only. Not financial advice. Market conditions can change and no outcome is guaranteed.

Why investors are watching this

  • First approved CRISPR therapy now commercializing
  • Pipeline expanding into oncology and diabetes
  • Strong cash position

Why this could grow

  • Gene editing addresses previously untreatable diseases
  • Platform applies to many disease areas
  • Partner revenue from Vertex

What could go wrong

  • Therapy uptake slower than hoped
  • Insurance and access challenges
  • Trial setbacks in pipeline programs

Ground floor potential

Why it may still be early

Gene editing as a treatment class is barely 2 years commercial.

How the industry may expand

Cell and gene therapy market growing >20% annually.

Compared to larger competitors

Far smaller than Vertex but on the same therapy.

Why this passed our AI quality filter

  • FDA-approved product on market
  • Big pharma partnership
  • Strong cash runway

📤 Smart Exit Guidance

Mixed exit signals

No urgent signals either way — a calm moment to reflect on your goals.

High-volatility phase

Worth monitoring

Why: Volatility for CRISPR Therapeutics is elevated (80/100), so swings in either direction may be larger than usual.

What changed: Daily price ranges have widened.

When investors sometimes consider selling

  • When volatility is elevated, some investors reduce position size to sleep better at night.
  • Reaching a personal goal (down payment, life milestone) is a common reason people take some profits regardless of price action.
  • Diversification matters — if a single position grows to dominate the portfolio, some investors rebalance.

Rebound potential analysis

Possible rebound factors — these are estimates, not guarantees.

  • Temporary volatility

    Volatile periods can see quick reversals in either direction. Reactions tend to fade faster than fundamentals shift.

Rebound timing and magnitude are uncertain. Markets can stay weak longer than expected.

Learn exit strategy basics
Mike is reading the latest news…

Long-term scenario calculator

Estimate possible outcomes across different time horizons. AI-generated estimates only — actual market performance may vary significantly.

Investment amount

$500

After 6 mo

Conservative

$460.98

Expected

$536.19

Bullish

$670.82

After 1 yr

Conservative

$425.00

Expected

$575.00

Bullish

$900.00

After 3 yr

Conservative

$307.06

Expected

$760.44

Bullish

$2916.00

After 5 yr

Conservative

$221.85

Expected

$1005.68

Bullish

$9447.84

AI-generated estimates only. Not financial advice. Market conditions can change and no outcome is guaranteed.

About this AI estimate

  • AI-generated estimate — not a prediction or guarantee.
  • Educational use only.
  • Market conditions can change rapidly.
  • Outcomes may vary significantly from any projection shown.

Where can I buy this?

Availability across popular investing platforms. Always confirm fees and limits in the app you choose.

  • Robinhood

    Fractional

  • Fidelity Investments

    Fractional shares from $1

    Fractional

  • Charles Schwab

    Stock Slices from $5

    Fractional

  • Webull

    Fractional

Educational availability info — not a recommendation of any broker.

Legal disclaimer

  • InvestMike uses AI-generated analysis and estimates that may contain inaccuracies or errors.
  • InvestMike is for informational and educational purposes only and does not provide financial advice.
  • All investing involves risk, including possible loss of money.
  • Users are solely responsible for their investment decisions.
  • Past performance does not guarantee future results.
  • AI-generated predictions are estimates only and should not be treated as guarantees.
  • InvestMike and its creators are not responsible for financial losses resulting from investment decisions.